Cardiac arrest is one of the most urgent and frightening medical emergencies a person can face. It occurs when the heart suddenly stops beating, halting blood flow to the brain and other vital organs. For survivors and their families, the event marks a profound turning point. The recovery process often involves not just physical healing, but also navigating the anxiety of potential recurrence. While the event itself is sudden, the path to stability involves a structured medical approach designed to save life and preserve future health.

Treatment is time-critical. Every second counts to restore a heartbeat and protect the brain from oxygen deprivation. Once the immediate crisis is resolved, the focus shifts to treating the underlying cause whether it be heart disease, an electrolyte imbalance, or a genetic condition to prevent it from happening again. Because the causes of cardiac arrest are diverse, medication plans are highly individualized based on what triggered the event and the patient’s overall heart function (American Heart Association, 2023).

Overview of treatment options for Cardiac Arrest

The treatment of cardiac arrest is divided into two distinct phases: immediate resuscitation and post-cardiac arrest care. During the event, the primary goal is to restart the heart and restore spontaneous circulation (ROSC). This typically involves a combination of Cardiopulmonary Resuscitation (CPR), defibrillation (electric shock), and emergency medications.

Once the heart is beating again, the treatment focus changes. The goals become stabilizing the heart rhythm, minimizing brain injury, and managing the underlying heart condition. While procedures like catheterization or the implantation of a defibrillator (ICD) are common, medications are the foundation of both immediate survival and long-term prevention.

Medications used for Cardiac Arrest

During the acute phase of resuscitation, vasopressors are the primary medication class used. Epinephrine (adrenaline) is the standard first-line drug administered intravenously. It is given to patients regardless of the specific heart rhythm causing the arrest. Clinical experience suggests that early administration of epinephrine significantly improves the chances of restarting the heart.

If the cardiac arrest is caused by a shockable rhythm—such as ventricular fibrillation—that does not respond to defibrillation alone, doctors introduce antiarrhythmic drugs. Amiodarone is the most frequently used medication in this setting. Lidocaine is often used as an alternative if amiodarone is unavailable or contraindicated.

In the post-resuscitation phase (after the patient is stable), long-term medications are prescribed to prevent recurrence. Beta-blockers, such as metoprolol or carvedilol, are standard for most survivors. These reduce the stress on the heart. If the arrest was caused by a blockage, antiplatelet agents (like aspirin) and statins are also prescribed to manage coronary artery disease (National Heart, Lung, and Blood Institute, 2022).

How these medications work

Epinephrine works by causing intense vasoconstriction. It tightens the blood vessels throughout the body, which directs the remaining blood flow toward the heart and brain. This increases the pressure in the arteries, making it more likely that the heart can pump effectively again during CPR.

Antiarrhythmics like amiodarone and lidocaine work by stabilizing the electrical activity of the heart cells. During cardiac arrest, the heart’s electrical signals are often chaotic. These drugs target sodium, potassium, and calcium channels in the cells to slow down nerve impulses and calm the electrical “storm,” allowing the heart to reorganize into a normal rhythm.

Beta-blockers, used during recovery, block the effects of adrenaline on the heart. By slowing the heart rate and lowering blood pressure, they reduce the heart’s demand for oxygen and make it less susceptible to dangerous rhythms triggered by stress (Mayo Clinic, 2023).

Side effects and safety considerations

Emergency medications like epinephrine are life-saving, so their immediate side effects are While high-dose medications (like epinephrine) are initially crucial for survival, in recovery they can temporarily cause a rapid heart rate or high blood pressure.

Long-term maintenance drugs require monitoring. Beta-blockers may cause fatigue, dizziness, and cold extremities. Extended amiodarone use risks thyroid, liver, or lung toxicity, necessitating regular blood tests and chest X-rays.

Survivors must take all medication doses precisely; missing them risks heart arrhythmia. Seek immediate medical attention for fainting, chest pain, or severe palpitations, as these can signal heart rhythm instability.

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. American Heart Association. https://www.heart.org
  2. Mayo Clinic. https://www.mayoclinic.org
  3. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov
  4. MedlinePlus. https://medlineplus.gov

Medications for Cardiac Arrest

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Cardiac Arrest.

Found 1 Approved Drug for Cardiac Arrest

THAM

Generic Name
Tromethamine

THAM

Generic Name
Tromethamine
Tham Solution (tromethamine injection) is indicated for the prevention and correction of metabolic acidosis. In the following conditions it may help to sustain vital functions and thus provide time for treatment of the primary disease: Metabolic Acidosis Associated with Cardiac Bypass Surgery. Tham Solution has been found to be primarily beneficial in correcting metabolic acidosis which may occur during or immediately following cardiac bypass surgical procedures. Correction of Acidity of ACD Blood in Cardiac Bypass Surgery. It is well known that ACD blood is acidic and becomes more acidic on storage. Tromethamine effectively corrects this acidity. Tham Solution may be added directly to the blood used to prime the pump-oxygenator. When ACD blood is brought to a normal pH range the patient is spared an initial acid load. Additional tromethamine may be indicated during cardiac bypass surgery should metabolic acidosis appear. Metabolic Acidosis Associated with Cardiac Arrest. Acidosis is nearly always one of the consequences of cardiac arrest and, in some instances, may even be a causative factor in arrest. It is important therefore, that the correction of acidosis should be started promptly with other resuscitative efforts. By correcting acidosis, Tham Solution (tromethamine injection) has caused the arrested heart to respond to resuscitative efforts after standard methods alone had failed. In these cases, tromethamine was given intraventricularly. It is to be noted, however, that such precariously ill patients often have died subsequently of causes unrelated to the administration of tromethamine. With administration by the peripheral venous route, metabolic acidosis has been corrected in a majority of patients. The success in reinstitution of cardiac rhythm by this means probably has not been of the same order of magnitude as with the intraventricular route.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances